Study of substrate specificity of a new peptide substrate of endothelin converting enzyme

   
Gureeva T.A.1, Kugaevskaya E.V.1, Pozdnev V.F.1, Prozorovskiy V.N.1, Elisseeva Yu.E.1, Solovyeva N.I.1

1. Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences
Section: Experimental/Clinical Study
PubMed Id: 17639718
Year: 2007  Volume: 53  Issue: 2  Pages: 172-180
The new fluorogenic hexapeptide substrate CMC-Ala-Gly-Gly-Trp-Phe-Arg was used as substrate for endothelin-converting enzyme (ECE), angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP). The specific inhibitors lisinopril (ACE) and thiorphan (NEP) were used for identification of these enzyme activities.
Download PDF:  
Keywords: CMC hexapeptide, endothelin-converting enzyme, angiotensin-converting enzyme, neutral endopeptidase, inhibitors
Citation:

Gureeva, T. A., Kugaevskaya, E. V., Pozdnev, V. F., Prozorovskiy, V. N., Elisseeva, Yu. E., Solovyeva, N. I. (2007). Study of substrate specificity of a new peptide substrate of endothelin converting enzyme. Biomeditsinskaya Khimiya, 53(2), 172-180.
This paper is also available as the English translation: 10.1134/S1990750807030055
References  
 2026 (vol 72)
 2025 (vol 71)
 2024 (vol 70)
 2023 (vol 69)